Abstract
A peripartum cardiomyopathy is a relatively rare heart disease that affects women in the third trimester of pregnancy and/or after giving birth, characterized by high variability of the course and prognosis with the potential for full restoration of left ventricular function. The pathophysiological mechanism in this disease is associated with prolactin degradation disorder, and therefore, the medications that suppress lactation have promising clinical significance.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
